SPY
757.12
+0.19%
QQQ
692.74
+0.33%
BTC/USD
78,183.90
−0.05%
DIA
517.65
+0.10%
GLD
356.15
+0.10%
TLT
81.65
−0.23%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Inogen Inc
INGN
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$6.86
-0.40
-5.51%
Last update: Oct 30, 4:00 PM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Options
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Earnings:
Q3 2026 Earnings in 3 days from now on Thu Nov 5th, after the market close
Conference Call:
Conference call scheduled in 3 days at 5:00 PM
Click to view the webcast
Inogen Financials
Inogen (INGN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est
Inogen (NASDAQ:INGN) lowers FY2026 sales outlook from $366.000 million-$373.000 million to $355.000 million-$361.000 million vs $369.267 million estimate.
Benzinga Newsdesk
PRO
Inogen Sees Q3 Sales $92.400M vs $98.967M Est
Inogen (NASDAQ:INGN) sees Q3 sales of $92.400 million vs $98.967 million analyst estimate.
Benzinga Newsdesk
PRO
Inogen Q2 Sales $95.084M Miss $95.233M Estimate
Inogen (NASDAQ:INGN) reported quarterly sales of $95.084 million which missed the analyst consensus estimate of $95.233 million by 0.16 percent. This is a 3.04 percent increase over sales of $92.277 million the same
Benzinga Newsdesk
PRO
Inogen Affirms FY2026 Sales Guidance of $366.000M-$373.000M vs $369.267M Est
Inogen (NASDAQ:INGN) affirms FY2026 sales outlook from $366.000 million-$373.000 million to $366.000 million-$373.000 million vs $369.267 million estimate.
Benzinga Newsdesk
PRO
Inogen Sees Q2 Sales $94.000M-$97.000M vs $97.250M Est
Inogen (NASDAQ:INGN) sees Q2 sales of $94.000 million-$97.000 million vs $97.250 million analyst estimate.
Benzinga Newsdesk
PRO
Inogen Q1 Adj. EPS $(0.14) Beats $(0.28) Estimate, Sales $85.109M Beat $82.350M Estimate
Inogen (NASDAQ:INGN) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.28) by 50 percent. This is a 27.27 percent decrease over losses of $(0.11) per share from the same
Benzinga Newsdesk
